Through the 90-day period concluding December 12, 2025, Aclaris Therapeutics's top three insider stakeholders include Chief Financial Officer Kevin Balthaser (92.61K shares), Director Christopher P. Molineaux (57.96K shares), President And COO Hugh M. Davis (26.75K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Braden Michael Leonard | 14,250,000 | 05 Aug, 2024 | |
| Capital Management Iii, Llc Foresite | 3,399,034 | 03 Nov, 2021 | |
| Neal Walker | CEO | 1,479,824 | 05 May, 2025 |
| Anand Mehra | 714,823 | 09 Jun, 2025 | |
| Andrew N Schiff | 448,415 | 09 Jun, 2025 | |
| Joseph Monahan | Chief Scientific Officer | 265,662 | 04 Mar, 2025 |
| Frank Ruffo | Chief Financial Officer | 201,883 | 14 Mar, 2022 |
| Kamil Ali-Jackson | Chief Legal Officer | 160,214 | 05 Jan, 2022 |
| David N. Gordon | Chief Medical Officer | 147,447 | 14 Jul, 2021 |
| James Loerop | Chief Business Officer | 103,306 | 04 Feb, 2025 |
| Kevin Balthaser | Chief Financial Officer | 92,608 | 04 Mar, 2025 |
| Christopher P. Molineaux | 57,956 | 09 Jun, 2025 | |
| Douglas J. Manion | Pres And CEO | 41,813 | 03 Jan, 2024 |
| William D. Humphries | 33,525 | 09 Jun, 2025 | |
| Andrew Kenneth William Powell | 33,523 | 04 Jun, 2024 | |
| Bryan M. Reasons | 28,732 | 04 Jun, 2024 | |
| Hugh M. Davis | President And COO | 26,750 | 04 Dec, 2025 |
| Maxine Gowen | 21,754 | 09 Jun, 2025 | |
| Vincent Milano | 17,316 | 09 Jun, 2025 | |
| Gail Cawkwell | Chief Medical Officer | 9,593 | 05 Jul, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Dec, 2025 | Hugh M. Davis | Common Stock | A | 26,750 | - | 26,750 | D | M |
| 06 Jun, 2025 | Vincent Milano | - | - | 17,316 | D | |||
| 06 Jun, 2025 | Vincent Milano | Common Stock | A | 4,793 | - | 17,316 | D | M |
| 06 Jun, 2025 | Christopher P. Molineaux | Common Stock | A | 4,793 | - | 57,956 | D | M |
| 06 Jun, 2025 | Anand Mehra | Common Stock | A | 4,793 | - | 714,823 | D | M |
| 06 Jun, 2025 | Maxine Gowen | Common Stock | A | 4,793 | - | 21,754 | D | M |
| 06 Jun, 2025 | Andrew N Schiff | Common Stock | A | 4,793 | - | 13,960 | D | M |
| 06 Jun, 2025 | William D. Humphries | Common Stock | A | 4,793 | - | 33,525 | D | M |
| 01 May, 2025 | Neal Walker | - | - | 1,482,799 | D | |||
| 01 May, 2025 | Neal Walker | Common Stock | A | 9,467 | - | 1,482,799 | D | M |
| 01 May, 2025 | Neal Walker | Common Stock | D | 2,975 | $1.38 | 1,479,824 | D | F |
| 01 Apr, 2025 | Neal Walker | Common Stock | A | 9,467 | - | 1,476,374 | D | M |
| 01 Apr, 2025 | Neal Walker | - | - | 1,473,332 | D | |||
| 01 Apr, 2025 | Neal Walker | Common Stock | D | 3,042 | $1.48 | 1,473,332 | D | F |
| 01 Mar, 2025 | Kevin Balthaser | Common Stock | A | 1,100 | - | 90,960 | D | M |
| 01 Mar, 2025 | Neal Walker | Common Stock | A | 9,466 | - | 1,470,184 | D | M |
| 01 Mar, 2025 | Joseph Monahan | Common Stock | A | 50,000 | - | 281,995 | D | M |
| 01 Mar, 2025 | Joseph Monahan | Common Stock | A | 10,925 | - | 292,920 | D | M |
| 01 Mar, 2025 | Kevin Balthaser | Common Stock | A | 2,375 | - | 93,335 | D | M |
| 01 Mar, 2025 | Neal Walker | Common Stock | D | 3,277 | $1.99 | 1,466,907 | D | F |